Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,956,792
  • Shares Outstanding, K 43,828
  • Annual Sales, $ 3,183 M
  • Annual Income, $ 1,335 M
  • EBIT $ 1,493 M
  • EBITDA $ 1,578 M
  • 60-Month Beta 0.84
  • Price/Sales 6.68
  • Price/Cash Flow 14.70
  • Price/Book 2.94

Options Overview Details

View History
  • Implied Volatility 54.37% (+4.74%)
  • Historical Volatility 44.15%
  • IV Percentile 90%
  • IV Rank 42.39%
  • IV High 92.62% on 08/25/25
  • IV Low 26.23% on 06/18/25
  • Expected Move (DTE 13) 31.28 (6.54%)
  • Put/Call Vol Ratio 1.18
  • Today's Volume 1,668
  • Volume Avg (30-Day) 2,410
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 34,232
  • Open Int (30-Day) 27,192
  • Expected Range 446.88 to 509.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 6.72
  • Number of Estimates 7
  • High Estimate 7.10
  • Low Estimate 6.23
  • Prior Year 6.63
  • Growth Rate Est. (year over year) +1.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
464.44 +2.95%
on 02/11/26
537.19 -10.99%
on 02/25/26
-7.20 (-1.48%)
since 02/06/26
3-Month
455.63 +4.94%
on 01/20/26
537.19 -10.99%
on 02/25/26
-11.15 (-2.28%)
since 12/05/25
52-Week
266.98 +79.10%
on 04/09/25
537.19 -10.99%
on 02/25/26
+170.48 (+55.41%)
since 03/06/25

Most Recent Stories

More News
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Dr. Martine Rothblatt , Chairperson and Chief Executive Officer, will...

UTHR : 478.16 (-1.42%)
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy

The phase 3 ADVANCE OUTCOMES study of ralinepag met its primary endpoint and several important secondary endpoints, including increasing odds of clinical improvement by 47%, in predominantly pre-treated...

UTHR : 478.16 (-1.42%)
Zoetis Stock: Is ZTS Underperforming the Healthcare Sector?

Zoetis has underperformed the healthcare sector over the past year, and analysts remain moderately optimistic about the stock’s outlook.

XLV : 152.70 (-0.79%)
ZTS : 121.43 (-0.65%)
UTHR : 478.16 (-1.42%)
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm

SFM : 80.25 (+4.34%)
COTY : 2.37 (-1.25%)
UTHR : 478.16 (-1.42%)
Why United Therapeutics (UTHR) Shares Are Sliding Today

Why United Therapeutics (UTHR) Shares Are Sliding Today

UTHR : 478.16 (-1.42%)
United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates

UTHR : 478.16 (-1.42%)
United Therapeutics: Q4 Earnings Snapshot

United Therapeutics: Q4 Earnings Snapshot

UTHR : 478.16 (-1.42%)
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2025. Full year 2025 revenues...

UTHR : 478.16 (-1.42%)
United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

United Therapeutics (UTHR) Q4 Earnings Report Preview: What To Look For

UTHR : 478.16 (-1.42%)
United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference

United Therapeutics Corporation (Nasdaq: UTHR ) announced today that Michael Benkowitz , President and Chief Operating Officer, will provide a company overview...

UTHR : 478.16 (-1.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 498.26
2nd Resistance Point 491.49
1st Resistance Point 484.83
Last Price 478.16
1st Support Level 471.39
2nd Support Level 464.62
3rd Support Level 457.96

See More

52-Week High 537.19
Last Price 478.16
Fibonacci 61.8% 433.97
Fibonacci 50% 402.09
Fibonacci 38.2% 370.20
52-Week Low 266.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar